We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current CARA market cap is 21.71M. The company's latest EPS is USD -25.9255 and P/E is -0.18.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 4.87M | 3M | 2.14M | 991k | 2.56M |
| Operating Income | -28.9M | -32.61M | -29.67M | -17.31M | -5.99M |
| Net Income | -28.03M | -32.34M | -30.7M | -20.02M | -12.48M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 19.89M | 135.08M | 23.03M | 41.87M | 20.97M |
| Operating Income | -111.68M | 5.39M | -89.08M | -87.54M | -121.5M |
| Net Income | -106.37M | 8.41M | -88.44M | -85.47M | -118.51M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 115.34M | 125.84M | 90.1M | 72.5M | 51.33M |
| Total Liabilities | 29.7M | 68.76M | 60.3M | 60.9M | 50.62M |
| Total Equity | 85.64M | 57.09M | 29.8M | 11.6M | 707k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 232.96M | 271.16M | 247.06M | 182.24M | 125.84M |
| Total Liabilities | 46.25M | 22.16M | 19.53M | 23.46M | 68.76M |
| Total Equity | 186.71M | 249M | 227.52M | 158.78M | 57.09M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -74.71M | -92.08M | -30.45M | -42.89M | -56.87M |
| Investing | 73.67M | 43.46M | 25.95M | 41.24M | 43.74M |
| Financing | 1.68M | 38.15M | -836k | -1.3M | -1.99M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -109.23M | -5.49M | -60.09M | -78.73M | -92.08M |
| Investing | -30.52M | -20.28M | -4.75M | 128.71M | 43.46M |
| Financing | 142.6M | 39.14M | 46.61M | 311k | 38.15M |
| Market Cap | 21.71M |
| Price to Earnings Ratio | -0.18 |
| Price to Sales Ratio | 1.04 |
| Price to Cash Ratio | 0.42 |
| Price to Book Ratio | 0.38 |
| Dividend Yield | - |
| Shares Outstanding | 4.57M |
| Average Volume (1 week) | 69.06k |
| Average Volume (1 Month) | 3.94M |
| 52 Week Change | -40.44% |
| 52 Week High | 13.80 |
| 52 Week Low | 2.7084 |
| Spread (Intraday) | 0.8 (15.09%) |
| Company Name | Cara Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.caratherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
